Molecular Mining Corporation was founded by PARTEQ Innovations, the technology-transfer arm of Queen's University, with researchers from the Departments of Chemistry and Computing Science at Queen's University, and a researcher from the U.S. National Institutes of Health. The company combines computer science and artificial intelligence with chemistry and biology to create advanced tools for extracting knowledge from vast stores of data, accelerating the development and discovery of new drugs. Queen's Working Ventures CMDF Scientific Breakthrough Fund is a $7-million venture capital fund, focusing on helping build leading-edge companies. Established as a partnership between Queen's University, Working Ventures Canadian Fund, and the Canadian Medical Discoveries Fund, and managed by PARTEQ, the fund invests in enterprises formed by Queen's researchers and graduates looking to commercialize research discoveries.
| Website | http://www.molecularmining.com |
| Revenue | $1 million |
| Employees | View employees |
| Address | 41 Linskey Way, Cambridge, Massachusetts 02142, US |
| Phone | +1 613-547-9752 |
| Industry | Metals & Mining General, Information Technology, Metals & Mining |
| Competitors | Roche, Thermo Fisher Scientific, Pfizer, Illumina, Bio-Rad Laboratories, QIAGEN, Biocon, Genetix +40 more (view full list) |
| SIC | SIC Code 67 Companies, SIC Code 679 Companies |
| NAICS | NAICS Code 52 Companies, NAICS Code 523 Companies |
Looking for a particular Molecular Mining employee's phone or email?
The Molecular Mining annual revenue was $1 million in 2026.
Molecular Mining is based in Cambridge, Massachusetts.
The NAICS codes for Molecular Mining are [52, 523].
The SIC codes for Molecular Mining are [67, 679].